secwatch.observer — SEC 8-K summary
======================================

Issuer:     RenovoRx, Inc. (RNXT)
CIK:        0001574094
Form:       8-K
Filed at:   2022-07-19T23:59:59+00:00
Accession:  0001493152-22-019760
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RenovoRx names James Ahlers CFO, Chris Lehman resigns; Ronald Kocak added as VP/Controller
--------------------------------------------------------------------------------

- CFO Christopher Lehman resigned effective July 15, 2022 to pursue a new opportunity.
- James Ahlers appointed CFO, Secretary and Treasurer effective July 15, 2022; will serve as principal financial and accounting officer.
- Ahlers is a consultant from Danforth Advisors; RenovoRx pays Danforth $450/hour for his services.
- Ronald B. Kocak, CPA, appointed VP and Controller; previously served as interim controller since October 2021.
- Ahlers has over 25 years life science finance experience, including CFO of Intarcia Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1574094/000149315222019760/0001493152-22-019760-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1574094/000149315222019760/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-019760

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer